Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

  • Vinod Burade1, 3Email author,
  • Subhas Bhowmick2,
  • Kuntal Maiti1,
  • Rishit Zalawadia1,
  • Harry Ruan1 and
  • Rajamannar Thennati2
BMC Cancer201717:405

https://doi.org/10.1186/s12885-017-3377-3

Received: 15 December 2016

Accepted: 19 May 2017

Published: 6 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Dec 2016 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Deep kamal karelia
10 Feb 2017 Reviewed Reviewer Report - Vijay Pandey
27 Feb 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 2
27 Feb 2017 Submitted Manuscript version 2
8 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 3
8 May 2017 Submitted Manuscript version 3
16 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 4
16 May 2017 Submitted Manuscript version 4
Publishing
19 May 2017 Editorially accepted
6 Jun 2017 Article published 10.1186/s12885-017-3377-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Sun Pharma Advanced Research Company Ltd.
(2)
Sun Pharmaceutical Industries Ltd.
(3)
Sun Pharma Advanced Research Centre (SPARC)

Advertisement